IPO registrations (S-1, F-1) · Registrants
BIOLASE, INC
- SEC CIK
- 811240 · filings on EDGAR ↗
- Former names
- BIOLASE TECHNOLOGY INC (1996–2012)
- Registration
- Form S-1, first filed 1997-07-10, last 2024-06-03; 12 initial registrations, 24 amendments
- Outcome
- Final prospectus filed 1998-08-25; declared effective 2007-04-17; withdrawal requested 2003-07-01
- Industry (SIC)
- Dental Equipment & Supplies 3843
- Incorporated in
- DE
- Business address
- 27042 TOWNE CENTRE DRIVE, SUITE 270, Foothill Ranch, CA 92610
- EIN
- 87-0442441
- EDGAR entity type
- operating
- Insiders and CEO pay
- BIOLASE, INC on the corporate pages
On this site
- Form 5500 plan sponsor: BIOLASE, INC. EXACT (EIN (EXACT))
- Federal award recipient: BIOLASE. INC Fuzzy (name and state)
- Form D issuer: BIOLASE, INC EXACT (CIK (EXACT))
- SEC filer: BIOLASE, INC EXACT (CIK (EXACT))
- Person page: Erin S Enright Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Paul N Clark Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 75
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1997-07-10 | S-1 | S-1 (registration) | BIOLASE TECHNOLOGY INC | 0000950148-97-001786 ↗ |
| 1998-08-25 | 424B1 | 424B1 (final prospectus) | BIOLASE TECHNOLOGY INC | 0001017062-98-001915 ↗ |
| 2003-07-01 | RW | RW (withdrawal request) | BIOLASE TECHNOLOGY INC | 0001017062-03-001484 ↗ |
| 2003-07-02 | RW | RW (withdrawal request) | BIOLASE TECHNOLOGY INC | 0001017062-03-001495 ↗ |
| 2004-02-27 | 424B4 | 424B4 (final prospectus) | BIOLASE TECHNOLOGY INC | 0001193125-04-031111 ↗ |
| 2005-11-29 | S-1 | S-1 (registration) | BIOLASE TECHNOLOGY INC | 0001193125-05-233561 ↗ |
| 2005-12-23 | S-1/A | S-1/A (amendment) | BIOLASE TECHNOLOGY INC | 0001193125-05-248482 ↗ |
| 2006-01-27 | S-1/A | S-1/A (amendment) | BIOLASE TECHNOLOGY INC | 0001193125-06-014256 ↗ |
| 2007-04-17 | EFFECT | EFFECT (declared effective) | BIOLASE TECHNOLOGY INC | 9999999995-07-001350 ↗ |
| 2008-06-17 | RW | RW (withdrawal request) | BIOLASE TECHNOLOGY INC | 0000892569-08-000893 ↗ |
| 2010-04-29 | EFFECT | EFFECT (declared effective) | BIOLASE TECHNOLOGY INC | 9999999995-10-001239 ↗ |
| 2011-08-25 | EFFECT | EFFECT (declared effective) | BIOLASE TECHNOLOGY INC | 9999999995-11-002572 ↗ |
| 2013-09-19 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-13-002724 ↗ |
| 2014-01-29 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-14-000247 ↗ |
| 2014-09-18 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-14-002817 ↗ |
| 2014-12-12 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-14-003684 ↗ |
| 2016-11-03 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-16-006149 ↗ |
| 2017-08-24 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-17-002191 ↗ |
| 2017-09-29 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-17-298538 ↗ |
| 2017-10-10 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-17-307198 ↗ |
| 2017-11-03 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-17-331925 ↗ |
| 2017-11-08 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-17-002916 ↗ |
| 2018-01-25 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-18-000225 ↗ |
| 2019-08-23 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-19-001957 ↗ |
| 2019-09-05 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-19-237970 ↗ |
| 2019-10-07 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-19-262950 ↗ |
| 2019-10-17 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-19-268694 ↗ |
| 2019-10-21 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-19-270929 ↗ |
| 2019-10-24 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-19-002379 ↗ |
| 2019-10-28 | 424B4 | 424B4 (final prospectus) | BIOLASE, INC | 0001193125-19-276357 ↗ |
| 2020-06-03 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-20-159634 ↗ |
| 2020-06-19 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-20-173995 ↗ |
| 2020-06-26 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-20-181151 ↗ |
| 2020-07-01 | 424B4 | 424B4 (final prospectus) | BIOLASE, INC | 0001193125-20-185338 ↗ |
| 2020-07-01 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-20-001612 ↗ |
| 2020-07-15 | S-1MEF | S-1MEF (added securities) | BIOLASE, INC | 0001193125-20-193425 ↗ |
| 2020-07-17 | 424B4 | 424B4 (final prospectus) | BIOLASE, INC | 0001193125-20-194809 ↗ |
| 2020-07-24 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-20-197890 ↗ |
| 2020-12-08 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-20-312195 ↗ |
| 2020-12-11 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-20-003495 ↗ |
| 2022-08-19 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-22-002452 ↗ |
| 2022-08-24 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-22-002483 ↗ |
| 2022-11-22 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-22-291211 ↗ |
| 2022-12-12 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-22-302202 ↗ |
| 2023-01-03 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-000878 ↗ |
| 2023-01-09 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-23-000075 ↗ |
| 2023-01-11 | 424B1 | 424B1 (final prospectus) | BIOLASE, INC | 0001193125-23-006580 ↗ |
| 2023-05-04 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-23-136119 ↗ |
| 2023-05-18 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-147276 ↗ |
| 2023-05-22 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-149885 ↗ |
| 2023-05-24 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-152517 ↗ |
| 2023-05-24 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-23-001519 ↗ |
| 2023-05-25 | 424B1 | 424B1 (final prospectus) | BIOLASE, INC | 0001193125-23-154212 ↗ |
| 2023-07-21 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-23-191344 ↗ |
| 2023-08-14 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-211151 ↗ |
| 2023-08-18 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-215256 ↗ |
| 2023-08-30 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-225045 ↗ |
| 2023-09-05 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-227778 ↗ |
| 2023-09-11 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-23-232572 ↗ |
| 2023-09-13 | S-1MEF | S-1MEF (added securities) | BIOLASE, INC | 0001193125-23-234731 ↗ |
| 2023-09-13 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-23-002646 ↗ |
| 2023-09-15 | 424B1 | 424B1 (final prospectus) | BIOLASE, INC | 0001193125-23-236278 ↗ |
| 2023-09-15 | 424B1 | 424B1 (final prospectus) | BIOLASE, INC | 0001193125-23-236279 ↗ |
| 2023-12-26 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-23-303130 ↗ |
| 2024-01-19 | S-1 | S-1 (registration) | BIOLASE, INC | 0001193125-24-010646 ↗ |
| 2024-01-31 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-24-019898 ↗ |
| 2024-02-07 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-24-025872 ↗ |
| 2024-02-09 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0001193125-24-029284 ↗ |
| 2024-02-13 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-24-000421 ↗ |
| 2024-02-15 | 424B1 | 424B1 (final prospectus) | BIOLASE, INC | 0001193125-24-036779 ↗ |
| 2024-03-27 | S-1/A | S-1/A (amendment) | BIOLASE, INC | 0000950170-24-037277 ↗ |
| 2024-04-02 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-24-000830 ↗ |
| 2024-04-22 | EFFECT | EFFECT (declared effective) | BIOLASE, INC | 9999999995-24-001065 ↗ |
| 2024-04-23 | 424B4 | 424B4 (final prospectus) | BIOLASE, INC | 0000950170-24-046924 ↗ |
| 2024-06-03 | S-1 | S-1 (registration) | BIOLASE, INC | 0001213900-24-049123 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Jones Jeffrey W | Director,Officer; Officer | President and CEO; President/CEO; (See Remarks) | 5 | 2006–2007 | |
| DURRIE DANIEL S | Director | 15 | 2006–2009 | ||
| LAIRD NEIL J | Director; Other | 12 | 2006–2010 | ||
| Anderton Robert M | Director | 8 | 2006–2010 | ||
| dArbeloff George V | Director | 9 | 2006–2010 | ||
| PIGNATELLI FEDERICO | Director; Director,Officer | Chairman and CEO; Executive Vice Chairman; Interim CEO; President | 21 | 2006–2012 | |
| Absolute Return Europe Fund | Other | 1 | 2007 | ||
| Largent James R | Director | 8 | 2007–2010 | ||
| Bateman Keith G | Officer | Exec. VP Global Sales | 1 | 2007 | |
| HARRISON RICHARD L | Officer | Exec. VP, CFO and Sec. | 1 | 2007 | |
| ST PHILIP JAKE | Director,Officer | CEO | 4 | 2008 | |
| Capallo Fred | Officer | Interim CFO; Interim Chief Financial Off. | 4 | 2008–2009 | |
| MULDER DAVID M | Director,Officer; Officer; Other | Chief Executive Officer; Chief Financial Officer | 7 | 2008–2010 | |
| Scott Brett L | Officer | Chief Financial Officer | 2 | 2009 | |
| WALLER GREGORY D | Director | 3 | 2009–2010 | ||
| Arrow Alexander K. | Director; Director,Officer; Officer | President and COO | 21 | 2010–2014 | |
| Nemoy Norman J. | Director | 8 | 2010–2013 | ||
| LICHTWARDT GREGORY | Director | 8 | 2010–2013 | ||
| Furry Frederick D. | Officer | Chief Financial Officer | 6 | 2010–2014 | |
| MOLL FREDERIC H | Director | 10 | 2013–2017 | ||
| ENRIGHT ERIN S. | Director | 2 | 2013 | person page Fuzzy | |
| FEINBERG LARRY N | TenPercentOwner | 19 | 2013–2020 | ||
| LOW SAMUEL BERNARD | Director | 2 | 2013 | ||
| TALEVICH JAMES R | Director | 11 | 2013–2018 | ||
| CLARK PAUL N | Director | 14 | 2014–2017 | person page Fuzzy | |
| Nugent Jeffrey M | Director,Officer | Acting Chief Executive Officer; Chief Executive Officer | 4 | 2014 | |
| LORD JONATHAN T MD | Director | 30 | 2014–2023 | ||
| Schuler Education Foundation | TenPercentOwner | 2 | 2014–2023 | ||
| SCHULER JACK W | Other; TenPercentOwner | 20 | 2014–2020 | ||
| DREYER DAVID C | Officer | SVP / Chief Financial Officer | 9 | 2015–2016 | |
| Flynn Harold C Jr. | Director,Officer | President and CEO | 15 | 2015–2017 | |
| Jack W. Schuler Living Trust | TenPercentOwner | 18 | 2015–2017 | ||
| Oracle Associates LLC | TenPercentOwner | 8 | 2016–2017 | ||
| ORACLE PARTNERS LP | TenPercentOwner | 11 | 2016–2020 | ||
| Nelson Mark Joseph | Officer | SVP & Chief Financial Officer | 3 | 2017 | |
| BEAVER JOHN R | Director,Officer; Officer | EVP & Chief Financial Officer; President & CEO; SVP & Chief Financial Officer | 20 | 2017–2023 | |
| Lanman Richard B. | Director | 8 | 2017–2021 | ||
| ORACLE INVESTMENT MANAGEMENT INC | TenPercentOwner | 1 | 2017 | ||
| Sato Garrett | Director | 10 | 2018–2021 | ||
| Norbe Todd | Director; Director,Officer | President and CEO | 13 | 2018–2020 | |
| ROPER JESS | Director | 9 | 2018–2023 | ||
| Wagner Elaine C | Director | 6 | 2018–2021 | ||
| DiTolla Michael | Director | 5 | 2019–2021 | ||
| Somerman Martha J. DDS, PhD | Director | 5 | 2021–2023 | ||
| Summerhays Carol Gomez DDS | Director | 5 | 2021–2023 | ||
| OLoughlin Kathleen T | Director | 5 | 2021–2023 | ||
| Yale Kenneth P. | Director | 3 | 2022–2023 | ||
| Bright Jennifer | Officer | Chief Financial Officer | 4 | 2022–2023 | |
| Sandor Steven | Officer | Chief Operating Officer | 3 | 2022–2023 | |
| GOLDMAN SACHS & CO. LLC | TenPercentOwner | 1 | 2023 | ||
| GOLDMAN SACHS GROUP INC | TenPercentOwner | 1 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-12-20 | BIOLASE, INC | Other Health Care | $2,732,914 | $2,732,914 | 1 | 1 |
| 2020-06-12 | BIOLASE, INC | Other Health Care | $6,912,000 | $6,912,000 | 9 | 1 |
| 2019-11-05 | BIOLASE, INC | Other Health Care | $3,999,987 | $3,999,987 | 4 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.